Mrs. Nurit Dahan-Farkas

Nurit Dahan-Farkas is a researcher whose work bridges medicinal chemistry and clinical reproductive health, with contributions spanning laboratory-based anticancer drug development and applied family medicine in South Africa. Published in journals such as PLoS ONE, European Journal of Medicinal Chemistry, Bioorganic and Medicinal Chemistry, and South African Family Practice, her scholarship reflects both experimental and practice-oriented expertise.

In medicinal chemistry and oncology, her studies focus on the synthesis and biological evaluation of novel nucleoside analogues and heterocyclic compounds targeting colorectal and other cancer cell lines. This work elucidates mechanisms of apoptosis, including caspase activation and mitochondrial pathways, highlighting selective cytotoxicity and the therapeutic potential of new molecular scaffolds.

Complementing this laboratory research, Dahan-Farkas has authored clinically focused reviews on emergency and long-acting reversible hormonal contraception in South Africa. These publications emphasize mechanism of action, safety, and public health implications, underscoring a commitment to improving reproductive health education and informed contraceptive choice within the primary care setting.